Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 10 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Revenue, operating profit and ordinary profit exceeded the previously announced figures because government-set prices were revised upward in the childcare support business, while occupancy at hospice-care homes in the nursing care business remained stable and profitability improved. Net income was below the previously announced figure because profitability declined at certain locations in the pharmaceutical, nursing care and childcare support businesses, resulting in the recognition of an ¥83 million impairment loss.
Impairment loss on fixed assets: ¥83 million
| Item | Details |
|---|---|
| Net Sales | ¥24,600 million → ¥24,850 million（+1.0%） |
| Operating profit | ¥640 million → ¥824 million（+28.8%） |
| Ordinary income | ¥630 million → ¥827 million（+31.3%） |
| Profit attributable to owners of the parent | ¥250 million → ¥200 million（-20.0%） |
| Net income per share | 89.42 yen → 71.83 yen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 10 February 2026 |
| Previous-period results | Revenue: ¥23,825 million; operating profit: ¥641 million; ordinary profit: ¥644 million; net income attributable to owners of the parent: ¥299 million; earnings per share: ¥113.95 (fiscal year ended March 2025) |
| Reason for the revision | Revenue, operating profit and ordinary profit exceeded the previously announced figures because government-set prices were revised upward in the childcare support business, while occupancy at hospice-care homes in the nursing care business remained stable and profitability improved. Net income was below the previously announced figure because profitability declined at certain locations in the pharmaceutical, nursing care and childcare support businesses, resulting in the recognition of an ¥83 million impairment loss. |
| Details and amount of extraordinary loss | Impairment loss on fixed assets: ¥83 million |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue, operating profit and ordinary profit exceeded the forecast because government-set prices were revised upward in the childcare support business, while occupancy at hospice-care homes in the nursing care business remained stable and profitability improved. On the other hand, net income was below the forecast because profitability declined at certain locations in the pharmaceutical, nursing care and childcare support businesses, resulting in the recognition of an ¥83 million impairment loss on fixed assets.